Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tara Pande"'
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 4, Pp 100245- (2021)
Summary: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and variants has led to significant mortality. We recently reported that an RNA-targeting CRISPR-Cas13 system, called pro
Externí odkaz:
https://doaj.org/article/f7fd26593e5e4550b3e9ebda34ee2d1a
Publikováno v:
Cell Reports Medicine
Cell Reports Medicine, Vol 2, Iss 4, Pp 100245-(2021)
Cell Reports Medicine, Vol 2, Iss 4, Pp 100245-(2021)
The COVID-19 pandemic caused by SARS-CoV-2 and variants has led to significant mortality. We recently reported that an RNA-targeting CRISPR-Cas13 system, termed prophylactic antiviral CRISPR in human (PAC-MAN), offered an antiviral strategy against S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2bc906dce49331e023a27e5fb629418
http://europepmc.org/articles/PMC7985958
http://europepmc.org/articles/PMC7985958
Autor:
Nicholas S. Heaton, Robert J. Debs, Girija Dhamdhere, Leiping Zeng, Drew Endy, Tara Pande, Marie La Russa, David B. Lewis, Lei S. Qi, Laine E. Goudy, Augustine Chemparathy, Yanxia Liu, Stephen Chmura, Timothy R. Abbott, Xueqiu Lin
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has infected more than 100,000 people worldwide with over 3,000 deaths since December 2019. There is no cure for COVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5d72f63d2187eb900abad2055862ecf
Autor:
Laine E. Goudy, Girija Dhamdhere, Stephen Chmura, Timothy R. Abbott, Lei S. Qi, Drew Endy, Marie La Russa, Augustine Chemparathy, Nicholas S. Heaton, Yanxia Liu, Xueqiu Lin, Robert J. Debs, David B. Lewis, Leiping Zeng, Tara Pande
Publikováno v:
Cell
The coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus, has highlighted the need for antiviral approaches that can target emerging viruses with no effective vaccines or pharmaceuticals. Here, we demonstrate a CRISPR-Cas13-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c57c6c4ae47a161b4a91c2e3b76c4db
https://pubmed.ncbi.nlm.nih.gov/33560913
https://pubmed.ncbi.nlm.nih.gov/33560913